Western Honduras Copán Population-Based Cancer Registry: Initial Estimates and a Model for Rural Central America.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
16
12
2021
pubmed:
17
12
2021
medline:
22
4
2022
Statut:
ppublish
Résumé
Population-based cancer registries (PBCRs) are critical for national cancer control planning, yet few low- and middle-income countries (LMICs) have quality PBCRs. The Central America Four region represents the principal LMIC region in the Western hemisphere. We describe the establishment of a PBCR in rural Western Honduras with first estimates for the 2013-2017 period. The Western Honduras PBCR was established through a collaboration of academic institutions and the Honduras Ministry of Health for collection of incident cancer data from public and private health services. Data were recorded using the Research Electronic Data Capture (REDCap) web-based platform with data monitoring and quality checks. Crude and age-standardized rates (ASRs) were calculated at the regional level, following WHO methodology. The web-based platform for data collection, available ancillary data services (eg, endoscopy), and technical support from international centers (United States and Colombia) were instrumental for quality control. Crude cancer incidence rates were 112.2, 69.8, and 154.6 per 100,000 habitants overall, males, and females, respectively (excluding nonmelanoma skin cancer). The adjusted ASRs were 84.2, 49.6, and 118.9 per 100,000 overall habitants, males, and females, respectively. The most common sites among men were stomach (ASR 26.0, 52.4%), colorectal (ASR 5.11, 10.15%), and prostate (ASR 2.7, 5.4%). The most common sites in women were cervix (ASR 34.2, 36.7%), breast (ASR 11.2, 12.3%), and stomach (ASR 10.8, 11.7%). The Copán-PBCR represents a successful model to develop cancer monitoring in rural LMICs. Innovations included the use of the REDCap platform and leverage of Health Ministry resources. This provides the first PBCR data for Honduras and the Central America Four and confirms that infection-driven cancers, such as gastric and cervical, should be priority targets for cancer control initiatives.
Identifiants
pubmed: 34914550
doi: 10.1200/GO.21.00273
pmc: PMC8691495
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1694-1702Subventions
Organisme : NCI NIH HHS
ID : P01 CA028842
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190612
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW009337
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA125588
Pays : United States
Références
Ann Oncol. 2005 Mar;16(3):489-511
pubmed: 15668262
Am J Epidemiol. 1999 Feb 15;149(4):372-8
pubmed: 10025481
J Glob Oncol. 2018 Jul;4:1-3
pubmed: 30084715
Cancer Causes Control. 2013 Feb;24(2):249-56
pubmed: 23224271
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cancer Epidemiol. 2018 Apr;53:93-98
pubmed: 29414637
J Gastrointest Cancer. 2015 Mar;46(1):21-8
pubmed: 25412859
Trans R Soc Trop Med Hyg. 2006 Mar;100(3):191-9
pubmed: 16274715
Cancer Causes Control. 2009 Nov;20(9):1663-70
pubmed: 19685147
Cancer. 2007 Apr 15;109(8):1607-16
pubmed: 17343277
Int J Cancer. 2002 Feb 1;97(4):536-41
pubmed: 11802219
IARC Sci Publ. 1991;(95):7-21
pubmed: 1894334
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241245
Lancet Oncol. 2008 Feb;9(2):159-67
pubmed: 18237850
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1103-11
pubmed: 16820326
Milbank Q. 2005;83(4):731-57
pubmed: 16279965
CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78
pubmed: 19897840
Cancer Causes Control. 2013 Feb;24(2):233-9
pubmed: 23263776
J Surg Res. 2019 Mar;235:167-170
pubmed: 30691791
Eur J Cancer. 2009 Mar;45(5):756-64
pubmed: 19128954
Eur J Cancer. 2009 Mar;45(5):747-55
pubmed: 19117750
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S74-S81
pubmed: 27678325
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):414-419
pubmed: 31719065
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241165